免疫とがんを支配するシンギュラリティ細胞の解明

• Project Area: Singularity biology
• Project/Area Number: 18H05417
• Research Category: Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)
• Allocation Type: Single-year Grants
• Review Section: Complex systems
• Research Institution: The University of Tokyo (2020); The University of Tokushima (2018-2019)
• Principal Investigator: 岡崎 拓 東京大学, 定量生命科学研究所, 教授 (00362468)
• Co-Investigator(Kenkyū-buntansha): 片貝 智哉 新潟大学, 医歯学系, 教授 (00324682)
• Project Period (FY): 2018-06-29 – 2023-03-31
• Project Status: Granted (Fiscal Year 2020)
• Budget Amount: ¥129,350,000 (Direct Cost: ¥99,500,000、Indirect Cost: ¥29,850,000); Fiscal Year 2021: ¥26,910,000 (Direct Cost: ¥20,700,000、Indirect Cost: ¥6,210,000); Fiscal Year 2020: ¥25,480,000 (Direct Cost: ¥19,600,000、Indirect Cost: ¥5,880,000); Fiscal Year 2019: ¥24,440,000 (Direct Cost: ¥18,800,000、Indirect Cost: ¥5,640,000); Fiscal Year 2018: ¥26,650,000 (Direct Cost: ¥20,500,000、Indirect Cost: ¥6,150,000)
• Keywords: 免疫 / がん / シンギュラリティ